Skip to content
Screener

Integra LifeSciences IART Long-term borrowings under securitization facility

Long-term borrowings under securitization facility at other companies

Taboola.com Ltd. logo
Taboola.com Ltd.TBLA
$133.1M+75.1%
Brink's, Inc. logo
Brink's, Inc.BCO
$5.29B+22.4%
Regal Rexnord logo
Regal RexnordRRX
$625.6M+65.2%
Service Properties Trust logo
Service Properties TrustSVC
$0
Kyndryl Holdings logo
Kyndryl HoldingsKD
$250M
Encore Capital Group logo
Encore Capital GroupECPG
$433.06M+42.8%

Other financials

Income statement

See full
Revenue$418.8M+0.8%
Gross profit$219.7M+5.0%
Operating income$19.3M+104%
Net income$4.5M+101%
EPS (diluted)$0.06+101%

Balance sheet

See full
Cash & equivalents$214.4M-1.6%
Total debt$2.0B+3.2%
Total equity$1.0B+0.5%
Total assets$3.6B-2.8%

Cash flow

See full
Operating cash flow$22.8M+156%
CapEx$12.3M-38.9%
Free cash flow$10.5M+193%

Valuation

See full
Market cap$1.34B+35.1%
Enterprise value$3.09B+15.4%
P/S0.8×+0.2×

Profitability

See full
Gross margin52.5%-0.1pp
Operating margin2.6%+1.3pp
Net margin-0.4%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-0.7%
Debt / equity1.9×+0.1×
Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept iart:SecuredLongTermDebtSecuritizationProgramNoncurrent.

The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000917520-26-000058
Line itemJune 30, 2026December 31, 2025
Accrued expenses and other current liabilities107,618130,493
Total current liabilities330,881455,981
Long-term borrowings under senior credit facility1,736,1051,729,556
Long-term borrowings under securitization facility92,600
Lease liability - operating leases162,660163,059
Deferred tax liabilities3,4705,664
Other liabilities194,397204,278
Total liabilities2,520,1132,558,538

Item 1. Financial Statements

FAQ

What is Integra LifeSciences's long-term borrowings under securitization facility?
Integra LifeSciences (IART) reported long-term borrowings under securitization facility of $92.6M in Q2 2026.
How has Integra LifeSciences's long-term borrowings under securitization facility changed year-over-year?
Integra LifeSciences's long-term borrowings under securitization facility decreased by 14.9% year-over-year, from $108.8M to $92.6M.
What does long-term borrowings under securitization facility mean?
This represents the long-term portion of debt obligations financed through a securitization program that is due beyond the next twelve months. It highlights the company's long-term capital structure strategy and the extent to which it leverages specific asset classes to secure financing. This metric is essential for evaluating the company's long-term leverage profile and the stability of its debt funding sources.

Ask your AI about Integra LifeSciences's long-term borrowings under securitization facility.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude